Gut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune Dysregulation.
Gut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune Dysregulation.
复制标题
DOI:
10.1016/j.clinthera.2015.04.002
复制
发表时间:
2015-05-01
影响因子:
3.2
通讯作者:
Theoharides TC
中科院分区:
文献类型:
--
作者:
Petra AI;Panagiotidou S;Hatziagelaki E;Stewart JM;Conti P;Theoharides TC
Gut microbiota regulate intestinal function and health. However, mounting evidence indicates that they can also influence the immune and nervous systems and vice versa. Here we reviewed the bidirectional relationship between the gut microbiota and the brain, termed microbiota-gut-brain (MGB) axis, and we discuss how it contributes to the pathogenesis of certain disorders, that may involve brain inflammation. Articles were chosen from Medline since 1980 using the key words anxiety, attention-deficit hypersensitivity disorder (ADHD), autism, cytokines, depression, gut, hypothalamic-pituitary-adrenal (HPA) axis, inflammation, immune system, microbiota, nervous system, neurologic, neurotransmitters, neuroimmune conditions, psychiatric, stress. Various afferent or efferent pathways are involved in the MGB axis. Antibiotics, environmental and infectious agents, intestinal neurotransmitters/neuromodulators, sensory vagal fibers, cytokines, essential metabolites, all convey information about the intestinal state to the CNS. Conversely, the HPA axis, the CNS regulatory areas of satiety and neuropeptides released from sensory nerve fibers affect the gut microbiota composition directly or through nutrient availability. Such interactions appear to influence the pathogenesis of a number of disorders in which inflammation is implicated such as mood disorder, autism-spectrum disorders (ASDs), attention-deficit hypersensitivity disorder (ADHD), multiple sclerosis (MS) and obesity. Recognition of the relationship between the MGB axis and the neuroimmune systems provides a novel approach for better understanding and management of these disorders. Appropriate preventive measures early in life or corrective measures such as use of psychobiotics, fecal microbiota transplantation and flavonoids are discussed.
登录
查看更多内容
影响因子:
7.7
作者:
Cani, Patrice D.;Amar, Jacques;Burcelin, Remy
通讯作者:
Burcelin, Remy
影响因子:
2.4
作者:
Adams JB;Johansen LJ;Powell LD;Quig D;Rubin RA
通讯作者:
Rubin RA
影响因子:
4
作者:
Barrett, E.;Ross, R. P.;Stanton, C.
通讯作者:
Stanton, C.
影响因子:
15.1
作者:
Chandler, N;Jacobson, S;Theoharides, TC
通讯作者:
Theoharides, TC
影响因子:
9.3
作者:
Asadi S;Theoharides TC
通讯作者:
Theoharides TC